We’ve been unlocking the potential of cortisol modulation for more than 25 years.
We’re leading the way in the research and development of cortisol modulators, molecules that regulate cortisol activity at the glucocorticoid receptor (GR). To date, we have discovered more than 1,000 selective proprietary cortisol modulators.
In 2012, we received FDA approval of a groundbreaking cortisol receptor blocker and the first approved treatment for hypercortisolism (Cushing’s syndrome).
Today, our team and collaborators continue to unlock the possibilities of cortisol modulation as a way to treat serious diseases. With more than 30 ongoing studies across a wide range of disease areas, including endocrinology, oncology, metabolism, and neurology, we remain dedicated to advancing the possibilities of cortisol modulation.
What began as a ripple of scientific truth is now poised to unleash a sea change of discovery representing a fundamental shift in the way we understand and treat disease.
Company Details
- Employees
- 634
- Founded
- -
- Address
- 101 Redwood Shores Pkwy, Redwood City,california 94065,united States
- Phone
- 16503273218
- in****@****ept.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- corcept.com
- HQ
- Redwood City, California
Corcept Therapeutics Questions
Corcept Therapeutics's helpline number is 16503273218
Corcept Therapeutics's website is corcept.com
Corcept Therapeutics's LinkedIn profile is https://www.linkedin.com/company/corcept-therapeutics
Corcept Therapeutics has
634 employees.
View email and phone details for 634
employees at Corcept Therapeutics.
Corcept Therapeutics's industry is
Biotechnology Research
Corcept Therapeutics's top competitors are
Ionis Pharmaceuticals, Inc.,
Biomarin Pharmaceutical Inc.,
Jazz Pharmaceuticals,
Acadia Pharmaceuticals Inc.,
Bridgebio,
Exelixis,
Crinetics Pharmaceuticals,
Alnylam Pharmaceuticals,
Cytokinetics,
Vertex Pharmaceuticals.
Corcept Therapeutics's support email address is info@corcept.com
Corcept Therapeutics's categories are Biotechnology Research
Corcept Therapeutics's founding year is 1998
